Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rank in Stocks #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Share Price
$59.98
Last synced: 2024-12-13
Market Cap
$1.22B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Longboard Pharmaceuticals, Inc. (LBPH)

Category

Stock price history for Longboard Pharmaceuticals, Inc. (LBPH)
Highest end of day price: $59.98 on 2024-12-01

Lowest end of day price: $16.35 on 2021-03-01
Stock price history of Longboard Pharmaceuticals, Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2024 1,066.59%
2023 27.45%
2022 -27.54%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH